Company Information
Industry 制造业
Company Introduction 安徽山河药用辅料股份有限公司及其前身自成立以来,一直专注于药用辅料的研发、生产和销售,经过十余年的发展,产品已由最初的5个品种增加到目前的21个品种、40余个规格,主要产品涵盖填充剂、黏合剂、崩解剂、润滑剂、包衣材料等常用口服固体制剂类药用辅料。其中:微晶纤维素、羟丙纤维素、羟丙甲纤维素、羧甲淀粉钠、硬脂酸镁和薄膜包衣粉被评定为安徽省高新技术产品,“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品称号,微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多年的经营管理成效,赢得了客户和同行的广泛认可。公司系全国医药技术市场协会药用辅料技术推广专业委员会副主任单位和国际药用辅料协会(中国)(IPEC-China)少数内资企业成员之一,连续多年荣膺慧聪网制药行业“制药原辅料十佳供应商”和2011年度“十大原辅料民族品牌”,全国药用辅料专业委员会和国际药用辅料网“2010年度最佳优秀辅料供应商”、中国化学制药工业协会“2013中国化学制药行业药用辅料优秀企业品牌”等称号;先后被惠氏制药有限公司、江苏先声药业有限公司和株洲千金药业股份有限公司等一批知名制药企业认定为年度优秀供应商或A类供应商等。
Main Business 药用辅料的研发、生产和销售。
Legal Representative 尹正龙
Top Executives
董事长:尹正龙
董事:雷韩芳,宋道才,刘路
独立董事:周建平,李健,林平,王宏
Top 5 Shareholder
Shareholder name Nature Holding Date
尹正龙限售股+流通A股26.90%30/09/2024
上海复星医药产业发展有限公司流通A股10.25%30/09/2024
刘涛流通A股1.67%30/09/2024
刘佳流通A股1.62%30/09/2024
中国对外经济贸易信托有限公司-外贸信托-仁桥泽源股票私募证券投资基金流通A股0.96%30/09/2024
Company Secretary 刘琦
Solicitors 安徽天禾律师事务所
Auditors 华普天健会计师事务所(特殊普通合伙)
Tel No 0554-2796116
Fax No 0554-2796150
Website www.shanhe01.com
Email lqlqlq676767@126.com;jzhzh@vip.qq.com
Company Address
Register: 安徽省淮南经济技术开发区河滨路2号
Office: 安徽省淮南经济技术开发区河滨路2号
Listing Date 15/05/2015
Shares Capital
Shares Capital: 234,447,103
Total A Share: 234,447,103
Listed A Share: 186,799,783
Non-tradable A Share: 47,647,320
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.690
DPS(RMB)* ¥ 0.250
NBV Per Share(RMB)* ¥ 3.543
Market Capitalization(RMB) 2.318B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.